% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Younas:282557,
author = {Younas, Neelam and Zerr, Inga},
title = {{O}xidative stress-induced stress granules: a central link
to protein aggregation in neurodegenerative diseases.},
journal = {Frontiers in neuroscience},
volume = {19},
issn = {1662-4548},
address = {Lausanne},
publisher = {Frontiers Research Foundation},
reportid = {DZNE-2025-01320},
pages = {1686571},
year = {2025},
abstract = {Intracellular aggregation of proteins such as Tau, TDP43,
FUS, prion protein, and α-synuclein is a major hallmark of
many major neurodegenerative diseases. Aberrant stress
granules (SGs) are emerging as key contributors to the
nucleation of toxic protein aggregates in these disorders.
SGs are dynamic, membrane less cytoplasmic assemblies that
form transiently through liquid-liquid phase separation
(LLPS) of RNA binding proteins (RBPs) containing low
complexity domains, together with stalled mRNAs, to help
cells cope with stress. While physiological SGs facilitate
cellular resilience to acute stress and undergo rapid
disassembly, chronic or excessive stress leads to persistent
SGs, driving pathological protein aggregation characteristic
of age related neurodegeneration. The inherent reversible
aggregation of RBPs crucial for cellular function
paradoxically exposes them to misfolding disorders. Notably,
recent findings expand this paradigm by demonstrating that
Tau itself participates in SG formation, with Tau-SG
interactions potentiating Tau aggregation and disease
progression in tauopathies. Despite these insights, the
precise cellular stressors and posttranslational
modifications (PTMs) governing the shift from physiological
granules to pathological aggregates remain poorly defined.
Emerging evidence highlights oxidative stress as a central
upstream mediator of this transition. In this perspective,
we synthesize current understanding of how SG dynamics
intersect with oxidative stress to potentiate protein
aggregation, proposing molecular mechanisms that bridge SG
biology and neurodegenerative disease. Elucidating these
pathways is essential for the development of targeted
therapeutic interventions for disorders such as Alzheimer's
disease and related tauopathies.},
keywords = {oxidative stress (Other) / pathological aggregation (Other)
/ persistent SGs (Other) / stress granules (Other) /
tauopathies (Other)},
cin = {AG Zerr},
ddc = {610},
cid = {I:(DE-2719)1440011-1},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41278186},
pmc = {pmc:PMC12634546},
doi = {10.3389/fnins.2025.1686571},
url = {https://pub.dzne.de/record/282557},
}